For Investors

​The information on this site is intended only for investors. All visitors should read the important advisory information by clicking here


Fulford (India) Limited, is the subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. known as MSD across the world (except in the US and Canada)./ MSD operates its human health business in India through three separate legal entities: MSD Pharmaceuticals Private Limited, Organon (India) Private Limited, and Fulford (India) Limited.

Since its existence in India, the company has moved quickly in laying the foundation for a business that is differentiated by its focus through launching innovative products relevant to India. MSD in India also has presence in Animal Health via MSD Animal Health with its vaccines facility located in Pune, Maharashtra.

MSD in India currently operates in various therapeutic areas in human health, including Metabolics, Vaccines, Critical Care, Oncology, Women's Health, Dermatology, Respiratory, and Primary Care, and offers a strong and diversified product portfolio of over 35 brands. Launching our best in class and first in class products at India specific pricing, and supporting capacity-building initiatives and disease management programs, MSD in India devotes extensive time and energy to increasing access to medicines and vaccines through far-reaching programs and collaborative approach. MSD follows a comprehensive multi-stakeholder approach in all therapeutic areas relevant to our products. We work with partners from the government, non-government and private sectors on innovative approaches to increase access and overcome barriers to healthcare in India

Our Vision

To make a difference in the lives of people globally through our innovative medicines, vaccines and animal health products. We are committed to being the premier, research-intensive biopharmaceutical company and are dedicated to providing leading innovations and solutions for today and the future.

What We Stand for

•It is our responsibility to address the health needs of patients and society through transformational science : delivering vaccines, medicines and animal health products that can help millions around the world.

•Focus on patients and anticipating customers' needs

•Commitments to expand access to our medicines and vaccines, and to improve global health